Ladarixin
Ladarixin (DF 2156A free base) is an orally active, non-competitive CXCR1/CXCR2 allosteric inhibitor that suppresses AKT, NF-κB, and angiogenesis, thereby slowing the progression of experimental human melanoma. It may be employed in research concerning COPD, asthma, and melanoma.
Product Specifications
CAS Number
849776-05-2
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.36% (May vary between batches)
Smiles
C[C@@H] (C (=O) NS (C) (=O) =O) c1ccc (OS (=O) (=O) C (F) (F) F) cc1
Molecular Formula
C11H12F3NO6S2
Molecular Weight
375.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb448452 100 µL
Phospho-Serine/Threonine Rabbit Polyclonal Antibody (Biotin)
Sign In for Pricing
View Details 
MR200593L3 10 µg
1700012B09Rik (NM_029306) Mouse Tagged Lenti ORF Clone
Sign In for Pricing
View Details K1165308 1.0 µg DNA
KRT3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details NBP2-72268CL1 0.1 mL
Mouse Monoclonal KBTBD7 Antibody (OTI1G3) [CoraFluor 1]
Sign In for Pricing
View Details MBS2093225-01 0.1 mL
Biotin-Linked Polyclonal Antibody to Immunoglobulin Associated Alpha (Iga)
Sign In for Pricing
View Details MBS2093225-02 0.2 mL
Biotin-Linked Polyclonal Antibody to Immunoglobulin Associated Alpha (Iga)
Sign In for Pricing
View Details